Hanson & Doremus Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-200
| Closed | -$25K | – | 412 |
|
|
2020
Q2 | $25K | Hold |
200
| – | – | 0.01% | 307 |
|
|
2020
Q1 | $17K | Hold |
200
| – | – | 0.01% | 353 |
|
|
2019
Q4 | $17K | Hold |
200
| – | – | ﹤0.01% | 383 |
|
|
2019
Q3 | $13K | Hold |
200
| – | – | ﹤0.01% | 392 |
|
|
2019
Q2 | $17K | Hold |
200
| – | – | 0.01% | 384 |
|
|
2019
Q1 | $18K | Hold |
200
| – | – | 0.01% | 362 |
|
|
2018
Q4 | $17K | Hold |
200
| – | – | 0.01% | 348 |
|
|
2018
Q3 | $19K | Hold |
200
| – | – | 0.01% | 362 |
|
|
2018
Q2 | $19K | Hold |
200
| – | – | 0.01% | 384 |
|
|
2018
Q1 | $16K | Hold |
200
| – | – | 0.01% | 410 |
|
|
2017
Q4 | $18K | Hold |
200
| – | – | 0.01% | 395 |
|
|
2017
Q3 | $19K | Hold |
200
| – | – | 0.01% | 377 |
|
|
2017
Q2 | $18K | Hold |
200
| – | – | 0.01% | 379 |
|
|
2017
Q1 | $18K | Hold |
200
| – | – | 0.01% | 364 |
|
|
2016
Q4 | $16.6K | Hold |
200
| – | – | 0.01% | 344 |
|
|
2016
Q3 | $19K | Hold |
200
| – | – | 0.01% | 322 |
|
|
2016
Q2 | $16K | Hold |
200
| – | – | 0.01% | 329 |
|
|
2016
Q1 | $16K | Hold |
200
| – | – | 0.01% | 337 |
|
|
2015
Q4 | $21K | Hold |
200
| – | – | 0.01% | 328 |
|
|
2015
Q3 | $21K | Hold |
200
| – | – | 0.01% | 315 |
|
|
2015
Q2 | $27K | Hold |
200
| – | – | 0.01% | 304 |
|
|
2015
Q1 | $25K | Hold |
200
| – | – | 0.01% | 312 |
|
|
2014
Q4 | $18K | Hold |
200
| – | – | 0.01% | 341 |
|
|
2014
Q3 | $14K | Hold |
200
| – | – | 0.01% | 343 |
|
|
2014
Q2 | $12K | Hold |
200
| – | – | 0.01% | 348 |
|
|
2014
Q1 | $14K | Hold |
200
| – | – | 0.01% | 334 |
|
|
2013
Q4 | $14K | Hold |
200
| – | – | 0.01% | 334 |
|
|
2013
Q3 | $14K | Hold |
200
| – | – | 0.01% | 322 |
|
|
2013
Q2 | $11K | Buy |
+200
| New | +$11K | 0.01% | 311 |
|